Mar 01, 99
|
| 07:30 ET |
CardioGenesis and Boston Scientific Terminate Exclusive International Distribution Agreement
|
|
Feb 09, 99
|
| 07:30 ET |
CardioGenesis Reports Results for the Fourth Quarter and Year Ended December 31, 1998
|
|
Feb 04, 99
|
| 07:31 ET |
CardioGenesis Comments on Medicare Reimbursement Recommendation
|
|
Jan 25, 99
|
| 08:06 ET |
CardioGenesis Comments on Blue Cross Blue Shield Association TEC Finding That TMR Improves Net Health Outcomes
|
|
Jan 06, 99
|
| 07:30 ET |
CardioGenesis and PLC Settle Patent Dispute
|
|
Dec 02, 98
|
| 23:52 ET |
CardioGenesis Granted 'Therapeutic and Diagnostic Agent Delivery' Patent For Combination TMR and Growth Factor Therapy
|
|
Oct 22, 98
|
| 07:45 ET |
CardioGenesis Reports Results for the Third Quarter Ended September 30, 1998
|
|
Jul 16, 98
|
| 07:30 ET |
CardioGenesis Reports Results for the Second Quarter Ended June 30, 1998
|
|
Jul 07, 98
|
| 07:57 ET |
CardioGenesis Completes Phase II Axcis PMR Randomized Trial
|
|
Jun 16, 98
|
| 09:53 ET |
CardioGenesis Strengthens Management Team with Appointment of New VP, Marketing
|
|
Apr 15, 98
|
| 05:00 ET |
CardioGenesis Reports Results for the First Quarter Ended March 31, 1998
|
|
Feb 04, 98
|
| 08:00 ET |
CardioGenesis Reports Results for the Fourth Quarter and Year Ended December 31, 1997
|
|
Nov 17, 97
|
| 08:02 ET |
CardioGenesis Appoints Robert C. Strauss to Board of Directors
|
|
Sep 17, 97
|
| 08:00 ET |
CardioGenesis Files Amended Patent Complaint Against PLC Medical Systems For Inequitable Conduct
|
|
Sep 05, 97
|
| 08:00 ET |
CardioGenesis Appoints New Board Member
|
|
Sep 04, 97
|
| 08:02 ET |
CardioGenesis Announces Preliminary Results of Feasibility Study for PMR(TM) System in 'No Option' Patients
|
|
Aug 01, 97
|
| 08:01 ET |
CardioGenesis Treats First U.S. Patient in Clinical Studies of Its Percutaneous Myocardial Revascularization System
|
|
Jul 15, 97
|
| 08:13 ET |
CardioGenesis Receives FDA Approval to Start Multi-Center Percutaneous, Myocardial Revascularization Clinical Trial
|
|
|